BioWorld

Feb. 3, 2004

BIO President Feldbaum To Retire; 'Timing Is Just Right'

WASHINGTON - Biotechnology Industry Organization President Carl Feldbaum on Monday said he'll retire and move to Idaho as soon as the group's executive committee hires his successor. (BioWorld Today) Read More

Targeted Genetics Adding $25.5M To Cash Via Public Stock Offering

Nastech Licenses RNAi Patents To Boost Tight Junctions Work

Icagen Brings In $19.5M For Clinical Programs, Research

Bush's 2005 Budget: More Funds For FDA, Vaccines

Other News To Note

U.S. Patent Disclosures

Today's news in brief

BioWorld

BioWorld briefs for June 15, 2026.

Ethyreal launches to treat the underlying cause of Graves’, TED

BioWorld

Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...

EHA 2026: With new lenses, a changing view on pediatric cancers

BioWorld

In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...

Microscopic image of chronic myeloid leukemia

Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid

BioWorld

Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...

Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs

BioWorld Science

Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...